Hepatocytes

are the primary sites of replication. HCV induces rearrangement of intracellular membranes resulting in formation of membranous webs, which serve as scaffolds for the assembly of replication complexes.[5] The viral genome consists of a single open reading frame (ORF), which is flanked by 5′ and 3′ nontranslated regions. This ORF encodes for a polyprotein that is cotranslationally and posttranslationally cleaved by host and viral proteases to yield at least 10 proteins. These include three structural (core, E1, and E2) and seven nonstructural (p7, NS2, NS3, NS4A, NS4B, NS5A, and NS5B) proteins. Infectious virus particles are assembled on the surface of cytoplasmic lipid droplets (LDs).[6] Thus, the viral life cycle is a complex multistep process. It requires a large number of host cellular proteins in addition to viral. The main goal of antiviral therapy is to cure CHC Selleck Torin 1 by a sustained elimination of the virus, also called sustained Ganetespib virological response (SVR, undetectable serum HCV-RNA for 6 months posttreatment cessation).[1] Is there a direct or indirect role for HCV in HCC? HCV has a remarkable ability to cause chronic

infection, which eventually leads to HCC. In the majority of CHC patients, inflammation results in fibrosis, followed by cirrhosis. It is well known that cirrhosis increases the risk for HCC. However, in a marginal case, HCC develops even in the absence of cirrhosis, signifying that HCV is directly oncogenic.[8] Over the past few years, enormous substantiation for the ability of viral proteins to modulate important host gene functions (transcription, cell proliferation, and apoptosis) have also emerged. The expression of core protein in transgenic mice can induce HCC.[9] Another multifunctional HCV protein, NS3, has

protease, helicase, and NTPase activities.[1, 10] NS3 also promotes carcinogenesis[11] by interacting with p53 in an NS3 sequence-dependent 上海皓元医药股份有限公司 manner.[12] HCV-Core protein expression both in vitro and in vivo has a direct effect on mitochondria and results in oxidative stress.[13] Oxidative stress, ROS, repeated liver damage and repair can eventually lead to HCC. Even though there have been advances, we do not understand the precise mechanism by which HCV infection results in HCC. Knowledge of this specific mechanism would allow us to intervene and prevent HCC. The frequency of HCC has tripled over the past 2 decades, while the 5-year survival rate has remained below 12% in the U.S.[4] In this issue of Hepatology, El-Shamy et al.[14] have asked an important question regarding the role of viral factors (HCV 1b) in HCC development. While it is known that viral factors impact the outcome of HCV therapy, this study further proposes the possibility of a link between HCV 1b isolates and HCC. The authors report specific sequences of the structural (Core) and nonstructural (NS3 and NS5A) proteins that associate with the development of HCC.